Frailty in randomised controlled trials for dementia or mild cognitive impairment measured via the frailty index: prevalence and prediction of serious adverse events and attrition

Table 1 Details of included trials

Trial	Trial ID	N participants	Length of follow-up	Mean age (years)	% Female
AD dementia trial	NCT00216593	408	24 months	83.32	80.9
MCI trial 1	NCT00236431	987	12 months	69.50	53.7
MCI trial 2	NCT00236574	1064	12 months	70.63	57.0

ISSN: 1758-9193